AMAZE™ Asthma Implementation QI Study

Study identifier:N3566000000

ClinicalTrials.gov identifier:NCT04901260

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

AMAZE™ Asthma Implementation Quality Improvement Study

Medical condition

asthma

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

117

Study type

Observational

Age

18 Years +

Date

Study Start Date: 25 Nov 2020
Primary Completion Date: 30 Jun 2021
Study Completion Date: 30 Jun 2021

Study design

Allocation: Non-randomized
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Jul 2022 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

Greater Austin Allergy, Evidera, Inc.

Inclusion and exclusion criteria